Chemed Corporation (CHE) To Go Ex-Dividend on February 23rd

Chemed Corporation (NYSE:CHEGet Free Report) announced a quarterly dividend on Friday, February 13th. Stockholders of record on Monday, February 23rd will be paid a dividend of 0.60 per share on Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, February 23rd.

Chemed has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 16 years. Chemed has a payout ratio of 8.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Chemed to earn $23.30 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 10.3%.

Chemed Trading Up 0.7%

Chemed stock traded up $3.24 during mid-day trading on Friday, hitting $475.35. The company’s stock had a trading volume of 124,633 shares, compared to its average volume of 168,831. The stock’s fifty day moving average is $444.77 and its two-hundred day moving average is $443.47. The firm has a market capitalization of $6.73 billion, a PE ratio of 25.14, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. Chemed has a 1 year low of $408.42 and a 1 year high of $623.60.

About Chemed

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Read More

Dividend History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.